Title:
抗腫瘍アルカロイドを用いる、組み合わせの治療法
Document Type and Number:
Japanese Patent JP6723815
Kind Code:
B2
Abstract:
The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM00104, and the use of these combinations in the treatment of cancer.
Inventors:
Victoria Moneo Okana
Hema Santa Maria Nunez
Luis Francisco Garcia Fernandez
Carlos Maria Garmarini
Maria Jose Guygen Navarro
Pablo Manuel Aviles Marine
Hema Santa Maria Nunez
Luis Francisco Garcia Fernandez
Carlos Maria Garmarini
Maria Jose Guygen Navarro
Pablo Manuel Aviles Marine
Application Number:
JP2016092369A
Publication Date:
July 15, 2020
Filing Date:
May 02, 2016
Export Citation:
Assignee:
Pharma Mar Sociedad Anonima
International Classes:
A61K31/4995; A61K31/40; A61K31/538; A61K31/7008; A61K33/243; A61P35/00; A61P35/02; A61P43/00
Domestic Patent References:
| JP2005501093A |
Other References:
Clinical Cancer Research,2002年,Vol.8,pp.3893-3903
European Journal of Cancer,2009年,Vol.45,pp.1153-1161
Annals of Oncology,2008年,Vol.19,pp.1802-1809
European Journal of Cancer,2009年,Vol.45,pp.1153-1161
Annals of Oncology,2008年,Vol.19,pp.1802-1809
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe